Core Laboratories
CLB
359 hedge funds and large institutions have $5.78B invested in Core Laboratories in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 135 increasing their positions, 123 reducing their positions, and 48 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
12% more call options, than puts
Call options by funds: $28.4M | Put options by funds: $25.4M
10% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 123
0.12% more ownership
Funds ownership: 113.24% → 113.36% (+0.12%)
4% less funds holding
Funds holding: 374 → 359 (-15)
8% less capital invested
Capital invested by funds: $6.3B → $5.78B (-$516M)
25% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$170M |
| 2 |
EIP
Epoch Investment Partners
New York
|
+$31M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$30.5M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$16.9M |
| 5 |
Select Equity Group
New York
|
+$15.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$46.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$33.7M |
| 3 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$33.6M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$30.8M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$26M |
CLB Hedge Fund Activity: Q3 2018 in Review
359 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2018, worth a combined $5.78B — down 8.2% from $6.3B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of CLB and 36 opened new positions — a net loss of 12 holders — while 123 trimmed existing stakes and 135 added.
The largest buyer was Royal London Asset Management, adding an estimated $170M. The largest seller was WCM Investment Management, cutting an estimated $46.8M.
- 359 institutional investors held Core Laboratories (CLB) as of Q3 2018, down from 374 in Q2 2018.
- Funds reported $5.78B of Core Laboratories stock for Q3 2018, down 8.2% quarter-over-quarter.
- 36 funds opened new Core Laboratories positions in Q3 2018 and 48 closed out, a net change of -12 holders.
- The largest Core Laboratories buyer in Q3 2018 was Royal London Asset Management, an estimated $170M added.
- The largest Core Laboratories seller in Q3 2018 was WCM Investment Management, an estimated $46.8M sold.
Based on aggregated 13F filings for Q3 2018.